Search bioRxiv⌕ Search

Biology subjects

McBride-Gagyi, S.

Publications and source records attributed to McBride-Gagyi, S..

3 recordsLinked to original sources

Cerclage Wire as an Affordable Alternative for Internal Fixation in Murine Critical Sized Defect Models

Critical sized defects (CSDs) are a serious challenge in orthopedics that require the development of more robust and effective treatments to improve quality of life for patients. Current CSD research is limited by the applicable and affordable animal models available. Mice would be the preferred species as they are cheaply housed and have many transgenic variations readily available; however, their small size makes CSD surgeries difficult and expensive. We propose the use of cerclage wires to achieve internal plate fixation. PEEK plates were secured to the right femur of 26 C57BL/6 mice using four cerclage wires to achieve modified double-loop fixation implemented through bicortical holes and defects were created. 10 received 3mm defects and 6 received 4mm defects that were left empty and were taken out to 20 weeks (Group E3, E4). Another 10 received 3mm defects that were filled with a morselized bone graft and were taken out to 8 weeks (Group G3). Blinded longitudinal x-ray grading by orthopedic surgeons was conducted on the empty defects for plate stability and wire fixation. All samples received microCT analysis at their endpoints. There were no significant differences in plate or wire stability between the empty groups and wire scores worsened negligibly over time. MicroCT analysis further supported wire integration as bone growth directly upon the wires was observed in all samples. The efficacy of this model in achieving non-union when left untreated was also confirmed via microCT. Further, only three mice in group G3 achieved union and two of these unions were not optimal. Our study is the first to successfully show that cerclage wire can be used in a murine CSD model to achieve affordability and clinical relevancy.

bioengineering↗

Substitution of Lead Tungstate for Lead Abellaite in a Nanoparticle-Alginate Nanocomposite as a Contrast Agent for Post-Mortem CT Imaging: In Vitro Bulk Performance Evaluation

Accurately assessing blood vascular networks is important in all organ systems in health, disease, and healing. However, methods to do so in a holistic fashion in post-mortem specimens have significant limitations. We have previously demonstrated proof of concept for a lead abbelaite nanoparticle and alginate nanocomposite contrast agent which would allow greatly improved vessel imaging using x-ray based imaging modalities like CT and microCT. Specifically the contrast is spectrally enhanced to easily allow segmentation from mineralized tissues and gelation is triggerable permitting better vascular perfusion. Here we expand upon that work by substituting lead tungstate nanoparticles. We found that delivery viscosity and radiopacity are largely unaffected. However, mechanical strength was negatively impacted as abellaite presence was lowered. In sum, these formulations have performed in bulk reasonably enough to warrant advancement to in vivo post-mortem evaluation in small animal models.

bioengineering↗

Systemically administered MSCs given 24hrs after osteotomy do not affect bone formation in rat distraction osteogenesis

Distraction osteogenesis is a unique postnatal bone formation employed by orthopaedic surgeons to treat many conditions, however, the overall time to external frame removal can be extensive. Any strategies that accelerate healing would improve patient care. Distraction osteogenesis research in the past decade has shown that direct stem cell implantation enhances new bone formation. Systemic implantation would be more clinically desirable. Systemically delivered stem cells have been shown to home to a mandibular distraction site; however, effects on bone formation have not been studied. Ten-week-old, male Sprague-Dawley rats underwent surgery to implant an external fixator-distractor and an osteotomy was performed. Twenty-four hours postoperatively, each rat received tail vein injections of either saline or 10^6 fluorescently labeled primary mesenchymal stem cells. Animals in the validation groups were euthanized two days after surgery and the femora processed for histology. Animals in the experimental groups were given five days of latency, then the femur was lengthened once daily for five days (0.75mm/day, 3.75mm total). Following four weeks of consolidation, the animals were euthanized and the femora were evaluated by microCT and histology to quantify new bone formation. Labeled stem cells were found at the distraction site in validation animals. However, there were no differences in any bone or soft tissue outcomes. Systemic stem cell administration 24 hours after surgery does not improve DO outcomes. It is possible that the animal model was not challenging enough to discriminate any augmentation provided by stem cells.

bioengineering↗